Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Homing Receptor Profiles of Lymphocytes Induced by Attenuated versus Live Plasmodium falciparum Sporozoites. | Vaccines (Basel) | 2022 | 36298634 | PubTator, text mining | PubMed |
| Chemokine/Interleukin Imbalance Aggravates the Pathology of Respiratory Syncytial Virus Infection. | J Clin Med | 2022 | 36294363 | PubTator, text mining | PubMed |
| Macrophage Phenotypes and Gene Expression Patterns Are Unique in Naturally Occurring Metabolically Healthy Obesity. | Int J Mol Sci | 2022 | 36293536 | PubTator, text mining | PubMed |
| Cell Component and Function of Tumor Microenvironment in Thyroid Cancer. | Int J Mol Sci | 2022 | 36293435 | PubTator, text mining | PubMed |
| Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis. | Diagnostics (Basel) | 2022 | 36292253 | PubTator, text mining | PubMed |
| Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma. | Cancers (Basel) | 2022 | 36291758 | PubTator, text mining | PubMed |
| Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling. | Biomolecules | 2022 | 36291580 | PubTator, text mining | PubMed |
| Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon-A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence. | Curr Oncol | 2022 | 36290857 | PubTator, text mining | PubMed |
| Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells. | MedComm (2020) | 2022 | 36276925 | PubTator, text mining | PubMed |
| A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses. | Front Immunol | 2022 | 36275774 | PubTator, text mining | PubMed |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. | Front Immunol | 2022 | 36275733 | PubTator, text mining | PubMed |
| Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles. | Cell Death Dis | 2022 | 36272970 | PubTator, text mining | PubMed |
| Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis. | J Oncol | 2022 | 36268282 | PubTator, text mining | PubMed |
| Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives. | Clin Cosmet Investig Dermatol | 2022 | 36267690 | PubTator, text mining | PubMed |
| Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis. | Front Endocrinol (Lausanne) | 2022 | 36267567 | PubTator, text mining | PubMed |
| Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma. | Nat Commun | 2022 | 36266311 | PubTator, text mining | PubMed |
| A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma. | Medicine (Baltimore) | 2022 | 36254009 | PubTator, text mining | PubMed |
| Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response. | Front Oncol | 2022 | 36248971 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient. | Front Immunol | 2022 | 36248860 | PubTator, text mining | PubMed |
| How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications. | Front Cardiovasc Med | 2022 | 36247456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=48